A comprehensive view of Approved Drugs / Devices. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Amgen's Imdelltra as second or later line of treatment for advanced small-cell lung cancer patients; globally about 330,00 people are diagnosed with lung cancer every year, with about 35,000 patients living in the US

Regeneron Pharma Applies for Patent on Methods of Treating Decreased Bone Mineral Density with Kringle Containing Transmembrane Protein 1 (Kremen1) Inhibitors

Australia: Eli Lilly and Co. Receives Patent for 'Compounds and methods targeting human tau'

Australia Patent: ELI LILLY AND Co., NEKTAR THERAPEUTICS File Application for 'DOSING REGIMENS FOR SELECTIVE TREG STIMULATOR RUR20KD-IL-2 AND RELATED COMPOSITIONS'

Australia: Sanofi Biotechnology, Regeneron Pharmaceuticals Receive Patent for 'Methods for treating or preventing asthma by administering an il-4r antagonist'

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count